Celldex Therapeutics

CLDX

Valor de mercado US$ 2,37 bi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 Fidelity Investments Boston, Massachusetts	US$ 189 mi	+US$ 84 mil	+2.891	+0%
2	2 State Street Boston, Massachusetts	US$ 87 mi	+US$ 15,9 mi	+546.124	+20%
3	3 BlackRock New York	US$ 85 mi	+US$ 3,04 mi	+104.647	+3%
4	4 RTW Investments New York	US$ 83,2 mi	–	–	–
5	5 Wellington Management Group Boston, Massachusetts	US$ 76,6 mi	-US$ 20 mi	-689.457	-20%
6	6 Vanguard Group Malvern, Pennsylvania	US$ 65,7 mi	+US$ 51,6 mil	+1.777	+0,1%
7	7 Viking Global Investors Stamford, Connecticut	US$ 63 mi	+US$ 14,3 mi	+491.207	+27%
8	8 RA Capital Management Boston, Massachusetts	US$ 55,9 mi	–	–	–
9	9 Redmile Group San Francisco, California	US$ 55,8 mi	+US$ 698 mil	+24.019	+1%
10	10 Eventide Asset Management Boston, Massachusetts	US$ 39 mi	–	–	–
11	KCM 11 Kynam Capital Management Princeton, New Jersey	US$ 30,5 mi	+US$ 11 mi	+379.225	+50%
12	12 Citadel Advisors Miami, Florida	US$ 28,1 mi	-US$ 2,65 mi	-91.086	-8%
13	13 Bellevue Group Kuesnacht, Switzerland	US$ 24,9 mi	+US$ 26,9 mi	+925.000	Nova
14	14 VR Adviser New York	US$ 23,3 mi	–	–	–
15	15 Geode Capital Management Boston, Massachusetts	US$ 22,7 mi	-US$ 418 mil	-14.389	-2%
16	16 Octagon Capital Advisors New York	US$ 20,5 mi	–	–	–
17	17 Polar Capital Holdings London, United Kingdom	US$ 17,5 mi	-US$ 17,5 mi	-602.580	-48%
18	18 Dimensional Fund Advisors Austin, Texas	US$ 16,5 mi	+US$ 567 mil	+19.514	+3%
19	19 Vivo Capital Palo Alto, California	US$ 15,1 mi	-US$ 2,02 mi	-69.720	-11%
20	20 Eversept Partners New York	US$ 14,9 mi	-US$ 2,44 mi	-84.065	-13%
21	21 Commodore Capital New York	US$ 14,5 mi	+US$ 8,64 mi	+297.613	+123%
22	22 Ikarian Capital Dallas, Texas	US$ 14,5 mi	–	–	–
23	23 T. Rowe Price Associates Baltimore, Maryland	US$ 14,4 mi	-US$ 15,1 mi	-520.923	-49%
24	24 Morgan Stanley New York	US$ 13 mi	-US$ 15,6 mi	-536.997	-53%
25	25 Goldman Sachs New York	US$ 11,9 mi	+US$ 3,96 mi	+136.293	+45%

Celldex Therapeutics CLDX Valor de mercado US$ 2,37 bi

Celldex Therapeutics

CLDX

Valor de mercado US$ 2,37 bi